Expectations
- Organism
- Homo sapiens
- Assay
- bulk RNA-seq
- Specimen/source
- patient tissue or biopsy
- Controls
- matched normal, adjacent normal, paired normal, healthy tissue control, or otherwise normal tissue control
Siftome Phase 3L
GSE141142Both case and control groups are present in the proposed grouping.
Each contrast group has at least 2 samples.
Processed data is marked available in the GEO index.
Unassigned or review-needed samples remain before analysis.
Warnings are present, but none are critical blockers.
Metadata quality is high enough to support downstream handoff.
Siftome proposed case and control labels, but no reviewer confirmation is stored yet.
Open the sample grouping CSV and confirm group labels before analysis.Both groups meet the minimum of 2 samples.
Confirm whether the cohort is large enough for the intended statistical analysis.Processed data availability is marked true in the GEO index.
Verify that downloaded processed files contain usable count or expression identifiers.3 review-needed samples and 0 unassigned samples remain.
Resolve ambiguous and unassigned samples before finalizing the contrast.No hard-excluded samples were detected by the current rules.
Record any manual exclusions in the downstream analysis notes.The dataset and sample accessions can be linked back to GEO.
Keep GEO dataset and sample links with exported metadata.Ask a bioinformatician to review grouping, count availability, exclusions, and design before DE.
No active review decisions affect this ranking.
No active manual corrections are applied to this dataset.
Homo sapiens
dataset_accession: GSE141142 organism: Homo sapiens dataset_title: An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
bulk RNA-seq
assay_type: bulk RNA-seq experiment_types: Expression profiling by high throughput sequencing platforms: GPL18573 Illumina NextSeq 500 (Homo sapiens) dataset_title: An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
Tumor vs unmatched normal
dataset_title: An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers experiment_types: Expression profiling by high throughput sequencing sample_context: GSM4196010: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female GSM4196011: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female GSM4196012: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: [Correction source preview truncated.]
Tissue
dataset_title: An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers sample_context: GSM4196010: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female GSM4196011: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female GSM4196012: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female GSM419 [Correction source preview truncated.]
breast cancer, ovarian cancer
dataset_title: An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers sample_context: GSM4196010: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female GSM4196011: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female GSM4196012: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female GSM419 [Correction source preview truncated.]
Eligible for Patient tissue tumor-vs-normal as Not suitable
dataset_accession: GSE141142 dataset_title: An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers organism: Homo sapiens assay_type: bulk RNA-seq sample_context: GSM4196010: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female GSM4196011: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female GSM4196012: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.re [Correction source preview truncated.]
Eligible for Patient tissue tumor-vs-normal as Not suitable
dataset_accession: GSE141142 dataset_title: An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers organism: Homo sapiens assay_type: bulk RNA-seq sample_context: GSM4196010: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female GSM4196011: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female GSM4196012: source_name=Breast; characteristics=cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.re [Correction source preview truncated.]
tumor sample (case)
sample_accession: GSM4196010 sample_title: 020_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196010 sample_title: 020_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196011 sample_title: 026_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196011 sample_title: 026_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196012 sample_title: 044_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196012 sample_title: 044_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196013 sample_title: 049_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196013 sample_title: 049_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196014 sample_title: 053_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: Neg; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196014 sample_title: 053_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: Neg; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196015 sample_title: 062_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196015 sample_title: 062_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196016 sample_title: 064_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: NA; brca.study.entry: Unknown; Sex: Female
review: ambiguous sample - Ambiguous sample metadata detected.
sample_accession: GSM4196016 sample_title: 064_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: NA; brca.study.entry: Unknown; Sex: Female
tumor sample (case)
sample_accession: GSM4196017 sample_title: 067_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: NA; brca.study.entry: Unknown; Sex: Female
review: ambiguous sample - Ambiguous sample metadata detected.
sample_accession: GSM4196017 sample_title: 067_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: NA; brca.study.entry: Unknown; Sex: Female
tumor sample (case)
sample_accession: GSM4196018 sample_title: 069_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196018 sample_title: 069_BC source_name: Breast characteristics: cancer type: BRCA; tissue: Breast; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196019 sample_title: 004_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA1; brca.study.entry: Non-Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196019 sample_title: 004_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA1; brca.study.entry: Non-Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196020 sample_title: 017_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196020 sample_title: 017_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196021 sample_title: 031_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: NA; brca.study.entry: Unknown; Sex: Female
review: ambiguous sample - Ambiguous sample metadata detected.
sample_accession: GSM4196021 sample_title: 031_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: NA; brca.study.entry: Unknown; Sex: Female
tumor sample (case)
sample_accession: GSM4196022 sample_title: 038_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196022 sample_title: 038_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: PR; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196023 sample_title: 043_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196023 sample_title: 043_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196024 sample_title: 047_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: NA; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196024 sample_title: 047_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: NA; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196025 sample_title: 051_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196025 sample_title: 051_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: Neg; brca.study.entry: Non-Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196026 sample_title: 056_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196026 sample_title: 056_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196027 sample_title: 058_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196027 sample_title: 058_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: SD; brca.status: BRCA1; brca.study.entry: Carrier; Sex: Female
tumor sample (case)
sample_accession: GSM4196028 sample_title: 065_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: NA; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
Included in derived sample grouping as tumor sample
sample_accession: GSM4196028 sample_title: 065_EOS source_name: Overy characteristics: cancer type: BRCA; tissue: Ovary; race: White; ethnicity: Non_Hispanic; sample.type: Tumor; reservation.type: FFPE; treatment.best.response: NA; brca.status: BRCA2; brca.study.entry: Carrier; Sex: Female
normal tissue (control)
sample_accession: GSM4196029 sample_title: 008Norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
Included in derived sample grouping as normal tissue
sample_accession: GSM4196029 sample_title: 008Norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
normal tissue (control)
sample_accession: GSM4196030 sample_title: 011Norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
Included in derived sample grouping as normal tissue
sample_accession: GSM4196030 sample_title: 011Norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
normal tissue (control)
sample_accession: GSM4196031 sample_title: 012Norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
Included in derived sample grouping as normal tissue
sample_accession: GSM4196031 sample_title: 012Norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
normal tissue (control)
sample_accession: GSM4196032 sample_title: 016Norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
Included in derived sample grouping as normal tissue
sample_accession: GSM4196032 sample_title: 016Norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
normal tissue (control)
sample_accession: GSM4196033 sample_title: 045norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
Included in derived sample grouping as normal tissue
sample_accession: GSM4196033 sample_title: 045norm source_name: Breast characteristics: cancer type: NA; tissue: Breast; race: NA; ethnicity: NA; sample.type: Normal; reservation.type: FFPE; treatment.best.response: NA; brca.status: NA; brca.study.entry: NA; Sex: Female
Original dataset metadata, sample metadata, source links, and GEO data availability flags.
Planned trusted source for processed count availability.
Planned source for curated expression experiment links.
Publication context when PubMed identifiers are already known.
No project feedback stored for this dataset.
dataset_accession: GSE141142 dataset_title: An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers organism: Homo sapiens assay_type: bulk RNA-seq processed_data_available: true raw_data_available: true submission_date: 2019-11-27 last_update_date: 2020-03-23 organization_name: University of Connecticut department: Not available public_date: 2019-11-28 experiment_types: Expression profiling by high throughput sequencing platforms: GPL18573 Illumina NextSeq 500 (Homo sapiens) sub_series: Not available bioproject: PRJNA592199 supplementary_files: TXT: GSE141142_GeneExpression_TPM.txt.gz series_type: Series
Samples currently treated as the comparison case group.
Samples currently treated as controls or baseline.
Samples with no explicit case or control marker.
No samples
Samples excluded from grouping by hard exclusion rules.
No samples
Samples that need manual review before trusting grouping.
No review decisions have been stored for this dataset.